Is Myovant Sciences Ltd (MYOV) Stock a Good Value Thursday?

Thursday, September 24, 2020 1:41 PM | InvestorsObserver Analysts

Myovant Sciences Ltd (MYOV) is near the top in its sector according to InvestorsObserver.

MYOV gets an overall rating of 58. That means it scores higher than 58% of stocks.

Myovant Sciences Ltd gets a 75 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 58
MYOV has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on MYOV!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.

The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Myovant Sciences Ltd Stock Today?

Myovant Sciences Ltd (MYOV) stock is down -8.2% while the S&P 500 is up 1.26% as of 1:31 PM on Thursday, Sep 24. MYOV has fallen -$1.79 from the previous closing price of $21.82 on volume of 931,707 shares. Over the past year the S&P 500 has risen 9.81% while MYOV is up 275.09%. MYOV lost -$2.85 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Myovant Sciences Ltd (MYOV) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like